Tymlos and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Tymlos (abaloparatide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Folic Acid, and have Osteoporosis post-menopausal.

The phase IV clinical study analyzes which people have Stroke when taking Tymlos. It is created by eHealthMe based on reports of 16,502 people who have side effects when taking Tymlos from the FDA, and is updated regularly.

What is Tymlos?

Tymlos has active ingredients of abaloparatide. eHealthMe is studying from 16,516 Tymlos users. Check the latest studies of Tymlos.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,311 drugs and 3,029 conditions by eHealthMe. Check the latest studies of Stroke.

On Jul, 16, 2026

16,502 people reported to have side effects when taking Tymlos.
Among them, 58 people (0.35%) have Stroke.

Among these 58 people:

How long have people been on Tymlos when they have Stroke? *

What is the gender of people who have Stroke when taking Tymlos? *

female: 94.74 %
male: 5.26 %

What is the age of people who have Stroke when taking Tymlos? *

What are other drugs people take besides Tymlos? *

What are other side effects people have besides Stroke? *

Fatigue (feeling of tiredness): 4 people, 6.90%
Nausea And Vomiting: 3 people, 5.17%
Panic Disorder: 3 people, 5.17%
Dyspnea (difficult or laboured breathing): 3 people, 5.17%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 5.17%
Drowsiness: 3 people, 5.17%
Nausea (feeling of having an urge to vomit): 3 people, 5.17%
Nervousness: 3 people, 5.17%
Pain: 3 people, 5.17%
Headache (pain in head): 3 people, 5.17%

What are the existing conditions these people have? *

Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 25 people, 43.10%
Osteoporosis (bones weak and more likely to break): 12 people, 20.69%
Senile Osteoporosis (weak bones with ageing): 11 people, 18.97%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 5.17%
Osteoporotic Fracture (fracture due to weak bone): 3 people, 5.17%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 3.45%
Neuropathy Peripheral (surface nerve damage): 2 people, 3.45%
Diabetes: 2 people, 3.45%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 1.72%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 1.72%

* Approximation only. Some reports may have incomplete information.

Do you take Tymlos and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tymlos:

Tymlos (16,516 reports)

Stroke treatments and more:

Stroke (334,635 reports)

Browse all side effects of Tymlos:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,311 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,029 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abaloparatide (the active ingredients of Tymlos) and Tymlos (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.